As of 4:23:44 PM GMT+1. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-181,240.00
-249,583.00
-299,919.00
-265,171.00
-119,935.00
Investing Cash Flow
163,797.00
-144,455.00
74,000.00
-7,000.00
4,000.00
Financing Cash Flow
5.00
470,855.00
187,040.00
318,183.00
176,967.00
End Cash Position
333,647.00
333,620.00
256,803.00
294,199.00
248,618.00
Capital Expenditure
--
--
-3,000.00
--
-3,000.00
Issuance of Capital Stock
5.00
500,406.00
200,000.00
336,000.00
187,550.00
Free Cash Flow
-181,240.00
-249,583.00
-302,919.00
-265,171.00
-122,935.00
12/31/2020 - 12/10/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CANTA.ST Cantargia AB (publ)
1.7000
+0.59%
ATORX.ST Alligator Bioscience AB (publ)
0.2495
+0.20%
EGTX.ST Egetis Therapeutics AB (publ)
7.00
0.00%
HNSA.ST Hansa Biopharma AB (publ)
39.74
+1.38%
ONCO.ST Oncopeptides AB (publ)
1.5840
+1.80%
XBRANE.ST Xbrane Biopharma AB (publ)
0.1752
+8.96%
VVY.AS Vivoryon Therapeutics N.V.
2.0850
+4.77%
BIOVIC-B.ST Biovica International AB (publ)
1.9960
-0.20%
SANION.ST Saniona AB (publ)
7.90
-1.74%
ACE.ST Ascelia Pharma AB (publ)
3.0000
+2.74%